ArticleBreast cancer research : BCR2019

MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.

Daniela Schwarzenbacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.